Indonesia Animal Health Market Size, Share, Opportunities, Covid-19 Impact And Trends By Type (Vaccines, Pharmaceuticals, Feed Additives, Others), By Animal Type (Companion Animal, Production Animal), By End-User (Vet Hospitals And Clinics, Animal Farms, Others) - Forecasts From 2021 To 2026

  • Published : Jun 2021
  • Report Code : KSI061614108
  • Pages : 106

Indonesia animal health market is evaluated at US$518.437 million for the year 2019 and is projected to grow at a CAGR of 4.04% to reach a market size of US$683.933 million by the year 2026. Animal health products are all those products that are specifically manufactured to cater to the needs of animals such as medicines, vaccines, and other nutritional products among others. The growth in the number of diseases in animals is anticipated to be one of the primary factors supplementing the demand for animal health products globally during the next five years. Similarly, on the other hand, a significant increase in the demand for food and food products has led to an upsurge in the livestock population in the country. This, combined with the rising outbreak of animal diseases is projected to supplement the market growth during the given time frame. Furthermore, the government is playing a significant role in bolstering the demand for animal health-related products since they are strategically taking steps to promote the health of animals. A surge in the number of animal welfare associations in rapid growth in the number of NGOs focusing on the care of stray animals is also propelling the business growth opportunities for the manufacturers over the forecast period. Moreover, an upsurge in animal breeding activities and the growing inclination of millennials towards the adoption of animals also provides an impetus to the market growth in the near future.

indonesia animal health market

The advent of COVID-19 had a positive impact on the Indonesian animal health market. This widespread scare of the pandemic resulted in the rising awareness about animal health in the country. Leading players in the Indonesian market have performed well during the pandemic with demand increasing from both existing pet owners and new pet owners that acquired pets during the crisis. With growth across all product categories, many leading players have gained share as they are top of mind and have established more extensive distribution in the market. Developments seen during the COVID-19 crisis are expected to lay the foundation for the further expansion of pet care in the Indonesian market during the forecast period. The expansion of the pet population during the pandemic will support continued demand.

The segmentation of the Indonesian animal health market has been done into type, animal type, end-user, distribution channel, and geography. By type, the classification of the market has been done into Vaccines, Pharmaceuticals, Feed Additives, Others. By animal type, the classification of the market has been done into Companion Animal, Production Animal. By end-user, the classification of the market has been done into Vet Hospitals And Clinics, Animal Farms, Others. By distribution channel, the classification of the market has been done into Online, Offline.

Encouraging government regulations will drive the market during the forecast period.

On February 10, 2020, the Ministry of Trade (MOT) issued regulation number 7/2020 on Buying Reference Prices at Farmer’s Level and Selling Reference Prices at Customer Level for several commodities, to ensure stable supply and prices. The poultry industry consumes a significant share of domestic animal feed supplies including animal health care products followed by aquaculture that consumes and cattle and swine the aforementioned MOT regulation sets up buying prices of chicken meat, day-old chicks, and egg due to the fluctuating prices of poultry products. To support the MOT regulation, and to ensure a balance of supply and demand of day-old chicks, on February 20, 2020, the Ministry of Agriculture (MOA) issued a circular letter on hatching eggs. The letter requires integrated poultry farmers to withdraw a total of 15 million of 19-days old hatching eggs from the hatching machine every week for February 4 – 29, 2020. The policy is expected to reduce day-old chick production by approximately 40 million head by the end of March 2020. At the end of December 2019, integrated poultry farmers produced a total of 262.9 million hatching eggs. The policy, combined with lower consumption due to COVID-19, is expected to lower overall poultry meat production in 2020.

Rising awareness of animal health amongst the farmers will be a tailwind to the growth of the market during the forecast period.

The growth of the market of animal health care market in Indonesia will be further fuelled by its increasing awareness amongst the farmers in the country.  According to a document published by the ReAct Asia-Pacific, the share of antimicrobials used in livestock production in Indonesia is dominantly in poultry farms rather than other livestock sectors. A study of antibiotic use in 360 small and medium scale commercial broiler farms in three provinces: West Java, East Java, South Sulawesi by the Ministry of Agriculture revealed the following results: Most of the farms (86%) operated under a supply contract with a major integrated poultry company. The decision on which antibiotics to use is influenced by the technical staff of the poultry farm supply contract company, who also provide the antibiotics for farmers (75%), followed by farmers’ previous experiences (9%), and sales staff of drug/feed/day-old-chick suppliers (7%). Most farm supply contract company technical staff (86%) and drug/feed/day-old-chick suppliers’ staff (50%) do not have a veterinary background. Most commonly used antibiotics were: Enrofloxacin (49.4%), amoxicillin/colistin (35.3%), trimethoprim/sulfadiazine (14.1%), and doxycycline (13.3%). Such developments are expected to increase the adoption of animal health care solutions in the country.

Competitive Insights

The players in the Indonesian animal health market are implementing various growth strategies to gain a competitive advantage over their competitors in this market. Major market players in the market have been covered along with their relative competitive strategies and the report also mentions recent deals and investments of different market players over the last few years. The company profiles section details the business overview, financial performance (public companies) for the past few years, key products and services being offered along with the recent deals and investments of these important players in the market.

Indonesia Animal Health Market Scope:

Report Metric


 The market size value in 2019

 US$518.437 million

 The market size value in 2026

 US$683.933 million

 Growth Rate

 CAGR of 4.04% from 2019 to 2026

 Base year


 Forecast period


 Forecast Unit (Value)

 USD Million

 Segments covered

 Type, Animal Type, End-user

 Companies covered

 Zoetis Inc., Merck & Co., Inc., Vetoquinol, Elanco, Bayer AG, ceva Santé Animale,   Virbac, IDEXX Laboratories, Phibro Animal Health, Boehringer Ingelheim

 Customization scope

 Free report customization with purchase


  • By Type

    • Vaccines

    • Pharmaceuticals

    • Feed Additives

    • Others

  • By Animal Type

    • Companion Animal

    • Production Animal

  • By End-User

    • Vet Hospitals And Clinics

    • Animal Farms

    • Others

1. Introduction
1.1. Market Definition
1.2. Market Segmentation

2. Research Methodology
2.1. Research Data
2.2. Assumptions

3. Executive Summary
3.1. Research Highlights

4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of End-Users
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. Indonesia Animal Health Market Analysis, by Type    
5.1. Introduction
5.2. Vaccines
5.3. Pharmaceuticals
5.4. Feed Additives
5.5. Others

6. Indonesia Animal Health Market Analysis, by Animal type    
6.1. Introduction
6.2. Companion Animal
6.3. Production Animal 

7. Indonesia Animal Health Market Analysis, by End-user    
7.1. Introduction
7.2. Vet Hospitals And Clinics
7.3. Animal Farms
7.4. Others 

8. Competitive Environment and Analysis
8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrativeness
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Vendor Competitiveness Matrix

9. Company Profiles 
9.1. Zoetis Inc.
9.2. Merck & Co., Inc.
9.3. Vetoquinol
9.4. Elanco
9.5. Eco Animal Health Group PLC
9.6. Ceva Santé Animale
9.7. Virbac
9.8. IDEXX Laboratories
9.9. Phibro Animal Health Corporation
9.10. Boehringer Ingelheim Company

Zoetis Inc.

Merck & Co., Inc.



Bayer AG

ceva Santé Animale


IDEXX Laboratories

Phibro Animal Health

Boehringer Ingelheim

Related Reports

Report Name Published Month Get Sample PDF